{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T17:59:02Z","timestamp":1784224742968,"version":"3.55.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.biopha.2016.11.073","type":"journal-article","created":{"date-parts":[[2016,11,29]],"date-time":"2016-11-29T01:48:09Z","timestamp":1480384089000},"page":"627-634","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["The role of NMDA receptor and nitric oxide\/cyclic guanosine monophosphate pathway in the antidepressant-like effect of dextromethorphan in mice forced swimming test and tail suspension test"],"prefix":"10.1016","volume":"85","author":[{"given":"Ehsan","family":"Sakhaee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sattar","family":"Ostadhadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Imran","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farbod","family":"Yousefi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Norouzi-Javidan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reyhaneh","family":"Akbarian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Chamanara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samira","family":"Zolfaghari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad-Reza","family":"Dehpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2016.11.073_bib0005","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1590\/1516-4446-2013-1294","article-title":"Prevalence of depression morbidity among Brazilian adults: a systematic review and meta-analysis","volume":"36","author":"Silva","year":"2014","journal-title":"Rev. Bras. Psiquiatr."},{"key":"10.1016\/j.biopha.2016.11.073_bib0010","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1176\/ajp.2006.163.12.2141","article-title":"Changes in the prevalence of major depression and comorbid substance use disorders in the United States between 1991 and 1992 and 2001\u20132002","volume":"163","author":"Compton","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.biopha.2016.11.073_bib0015","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0193-953X(18)30164-3","article-title":"Treatment resistance in unipolar depression and other disorders: diagnostic concerns and treatment possibilities","volume":"16","author":"Nelsen","year":"1993","journal-title":"Psychiatr. Clin. North. Am."},{"key":"10.1016\/j.biopha.2016.11.073_bib0020","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0924-977X(98)00004-2","article-title":"Treatment resistant depression: methodological overview and operational criteria","volume":"9","author":"Souery","year":"1999","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.biopha.2016.11.073_bib0025","first-page":"1","article-title":"Treatment-resistant depression","volume":"10","author":"Kay","year":"2006","journal-title":"Psychiatry"},{"key":"10.1016\/j.biopha.2016.11.073_bib0030","first-page":"16","article-title":"Treatment-resistant depression","volume":"67","author":"Souery","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.biopha.2016.11.073_bib0035","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nrd2462","article-title":"Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders","volume":"7","author":"Sanacora","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biopha.2016.11.073_bib0040","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0014-2999(99)00330-1","article-title":"Antidepressants for the new millennium","volume":"375","author":"Skolnick","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2016.11.073_bib0045","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.biopsych.2007.03.017","article-title":"Increased levels of glutamate in brains from patients with mood disorders","volume":"62","author":"Hashimoto","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.biopha.2016.11.073_bib0050","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0006-8993(95)00057-W","article-title":"Alterations in the N-methyl-d-asparatate (NMDA) receptor complex in the frontal cortex of suicide victims","volume":"675","author":"Nowak","year":"1995","journal-title":"Brain. Res."},{"key":"10.1016\/j.biopha.2016.11.073_bib0055","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1097\/00001756-200109170-00043","article-title":"Asymmetrical reductions of hippocampal NMDAR1 glutamate receptor mRNA in the psychoses","volume":"12","author":"Law","year":"2001","journal-title":"Neuroreport"},{"key":"10.1016\/j.biopha.2016.11.073_bib0060","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.biopha.2016.11.073_bib0065","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.biopha.2016.11.073_bib0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pbb.2015.11.009","article-title":"Involvement of N-methyl-d-aspartate receptors in the antidepressant-like effect of 5-hydroxytryptamine 3 antagonists in mouse forced swimming test and tail suspension test","volume":"141","author":"Kordjazy","year":"2016","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.biopha.2016.11.073_bib0075","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1139\/cjpp-2015-0429","article-title":"Fluoxetine reverses the behavioral despair induced by neurogenic stress in mice: role of N-methyl D-aspartate and opioid receptors","volume":"94","author":"Haj-Mirzaian","year":"2016","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.biopha.2016.11.073_bib0080","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.brainresbull.2016.03.004","article-title":"Involvement of NMDA receptors and l-arginine\/nitric oxide\/cyclic guanosine monophosphate pathway in the antidepressant-like effects of topiramate in mice forced swimming test","volume":"122","author":"Ostadhadi","year":"2016","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.biopha.2016.11.073_bib0085","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.mehy.2012.02.012","article-title":"An extension of hypotheses regarding rapid-acting treatment-refractory, and conventional antidepressant activity of dextromethorphan and dextrorphan","volume":"78","author":"Lauterbach","year":"2012","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.biopha.2016.11.073_bib0090","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.biopsych.2009.04.029","article-title":"Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression","volume":"66","author":"Price","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.biopha.2016.11.073_bib0095","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.expneurol.2007.06.013","article-title":"A comparison of the binding profiles of dextromethorphan, memantine, fluoxetine and amitriptyline: treatment of involuntary emotional expression disorder","volume":"207","author":"Werling","year":"2007","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.biopha.2016.11.073_bib0100","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.pharmthera.2010.04.003","article-title":"Sigma receptors: potential targets for a new class of antidepressant drug","volume":"127","author":"Fishback","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.biopha.2016.11.073_bib0105","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.bbr.2015.03.024","article-title":"Involvement of AMPA receptors in the antidepressant-like effects of dextromethorphan in mice","volume":"295","author":"Nguyen","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.biopha.2016.11.073_bib0110","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.pbb.2006.06.005","article-title":"Animal models of depression in drug discovery: a historical perspective","volume":"84","author":"McArthur","year":"2006","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.biopha.2016.11.073_bib0115","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0165-0173(00)00018-7","article-title":"Roles of NMDA receptor activity and nitric oxide production in brain development","volume":"32","author":"Contestabile","year":"2000","journal-title":"Brain. Res. Rev."},{"key":"10.1016\/j.biopha.2016.11.073_bib0120","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0166-4328(02)00084-0","article-title":"Reduction of cGMP and nitric oxide has antidepressant-like effects in the forced swimming test in rats","volume":"134","author":"Heiberg","year":"2002","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.biopha.2016.11.073_bib0125","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0014-2999(99)00191-0","article-title":"Nitric oxide synthase inhibitors have antidepressant-like properties in mice: 1. Acute treatments are active in the forced swim test","volume":"372","author":"Harkin","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2016.11.073_bib0130","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/eurheartj\/ehr304","article-title":"Nitric oxide synthases: regulation and function","volume":"33","author":"F\u00f6rstermann","year":"2012","journal-title":"Eur. Heart. J."},{"key":"10.1016\/j.biopha.2016.11.073_bib0135","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.brainresbull.2015.11.020","article-title":"Possible involvement of nitrergic and opioidergic systems in the modulatory effect of acute chloroquine treatment on pentylenetetrazol induced convulsions in mice","volume":"121","author":"Hassanipour","year":"2016","journal-title":"Brain Res. Bull"},{"key":"10.1016\/j.biopha.2016.11.073_bib0140","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ejphar.2014.10.002","article-title":"Anti-pruritic activity of pioglitazone on serotonin-induced scratching in mice: possible involvement of PPAR-gamma receptor and nitric oxide","volume":"744","author":"Rajaba","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2016.11.073_bib0145","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/ced.12605","article-title":"Involvement of nitric oxide in serotonin\u2010induced scratching in mice","volume":"40","author":"Ostadhadi","year":"2015","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.biopha.2016.11.073_bib0150","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.pbb.2015.04.016","article-title":"Chloroquine-induced scratching is mediated by NO\/cGMP pathway in mice","volume":"134","author":"Foroutan","year":"2015","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.biopha.2016.11.073_bib0155","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1097\/00001756-200011270-00022","article-title":"Evidence for dual effects of nitric oxide in the forced swimming test and in the tail suspension test in mice","volume":"11","author":"da Silva","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.biopha.2016.11.073_bib0160","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0166-4328(02)00312-1","article-title":"Antidepressant-and anxiolytic-like effects of selective neuronal NOS inhibitor 1-(2-trifluoromethylphenyl)-imidazole in mice","volume":"140","author":"Volke","year":"2003","journal-title":"Behav. Brain. Res."},{"key":"10.1016\/j.biopha.2016.11.073_bib0165","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S0005-2728(99)00024-9","article-title":"Guanylate cyclase and the\u22c5 NO\/cGMP signaling pathway","volume":"1411","author":"Denninger","year":"1999","journal-title":"Biochim. Biophys. Acta-Bioenerg."},{"key":"10.1016\/j.biopha.2016.11.073_bib0170","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/sj.bjp.0704569","article-title":"NO as a signalling molecule in the nervous system","volume":"135","author":"Esplugues","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2016.11.073_bib0175","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejphar.2016.03.034","article-title":"Involvement of nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of tropisetron and ondansetron in mice forced swimming test and tail suspension test","volume":"780","author":"Haj-Mirzaian","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2016.11.073_bib0180","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s00213-006-0326-2","article-title":"Inhibition of neuronal nitric oxide synthase in the rat hippocampus induces antidepressant-like effects","volume":"185","author":"Joca","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.biopha.2016.11.073_bib0185","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.neulet.2015.12.006","article-title":"The involvement of NMDA receptor\/NO\/cGMP pathway in the antidepressant like effects of baclofen in mouse force swimming test","volume":"612","author":"Khan","year":"2016","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.biopha.2016.11.073_bib0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00210-015-1203-5","article-title":"Involvement of NO\/cGMP pathway in the antidepressant-like effect of gabapentin in mouse forced swimming test","volume":"389","author":"Ostadhadi","year":"2016","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.biopha.2016.11.073_bib0195","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.euroneuro.2007.07.011","article-title":"Nitric oxide involvement in the antidepressant-like effects of acute lithium administration in the mouse forced swimming test","volume":"18","author":"Ghasemi","year":"2008","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.biopha.2016.11.073_bib0200","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.euroneuro.2003.08.010","article-title":"Nitric oxide synthase inhibitors augment the effects of serotonin re-uptake inhibitors in the forced swimming test","volume":"14","author":"Harkin","year":"2004","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.biopha.2016.11.073_bib0205","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00213-009-1609-1","article-title":"NMDA receptor\/nitrergic system blockage augments antidepressant-like effects of paroxetine in the mouse forced swimming test","volume":"206","author":"Ghasemi","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.biopha.2016.11.073_bib0210","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.bbr.2005.06.031","article-title":"Effects of potassium channel inhibitors in the forced swimming test: possible involvement of L-arginine-nitric oxide-soluble guanylate cyclase pathway","volume":"165","author":"Kaster","year":"2005","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.biopha.2016.11.073_bib0215","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.biopha.2016.05.035","article-title":"Pharmacological evidence for the involvement of the NMDA receptor and nitric oxide pathway in the antidepressant-like effect of lamotrigine in the mouse forced swimming test","volume":"82","author":"Ostadhadi","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2016.11.073_bib0220","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1007\/s00213-015-4004-0","article-title":"Evidence for the involvement of NMDA receptors in the antidepressant-like effect of nicotine in mouse forced swimming and tail suspension tests","volume":"232","author":"Haj-Mirzaian","year":"2015","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.biopha.2016.11.073_bib0225","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/1440-1681.12518","article-title":"Involvement of opioid system in antidepressant\u2013like effect of the cannabinoid CB1 receptor inverse agonist AM\u2010251 after physical stress in mice","volume":"43","author":"Ostadhadi","year":"2015","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.biopha.2016.11.073_bib0230","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ejphar.2014.03.053","article-title":"Opioid\/NMDA receptors blockade reverses the depressant-like behavior of foot shock stress in the mouse forced swimming test","volume":"735","author":"Haj-Mirzaian","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2016.11.073_bib0235","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ejphar.2015.06.030","article-title":"Elevated level of nitric oxide mediates the anti-depressant effect of rubidium chloride in mice","volume":"762","author":"Kordjazy","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2016.11.073_bib0240","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.biopha.2016.08.015","article-title":"Lithium attenuated the behavioral despair induced by acute neurogenic stress through blockade of opioid receptors in mice","volume":"83","author":"Khaloo","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2016.11.073_bib0245","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1177\/0269881109104845","article-title":"NMDA receptor antagonists augment antidepressant-like effects of lithium in the mouse forced swimming test","volume":"24","author":"Ghasemi","year":"2009","journal-title":"J. Psychopharmacol"},{"key":"10.1016\/j.biopha.2016.11.073_bib0250","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0166-4328(03)00069-X","article-title":"Involvement of NMDA receptors and L-arginine-nitric oxide pathway in the antidepressant-like effects of zinc in mice","volume":"144","author":"Rosa","year":"2003","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.biopha.2016.11.073_bib0255","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.mehy.2011.02.003","article-title":"Dextromethorphan as a potential rapid-acting antidepressant","volume":"76","author":"Lauterbach","year":"2011","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.biopha.2016.11.073_bib0260","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","article-title":"The tail suspension test: a new method for screening antidepressants in mice","volume":"85","author":"Steru","year":"1985","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.biopha.2016.11.073_bib0265","first-page":"327","article-title":"Behavioral despair in mice: a primary screening test for antidepressants","volume":"229","author":"Porsolt","year":"1977","journal-title":"Arch. Int. de Pharmacodynamie et de Th\u00e9rapie"},{"key":"10.1016\/j.biopha.2016.11.073_bib0270","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.pharep.2016.07.006","article-title":"Possible involvement of ATP-sensitive potassium channels in the antidepressant-like effect of baclofen in mouse forced swimming test","volume":"68","author":"Nazari","year":"2016","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.biopha.2016.11.073_bib0275","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ejphar.2016.09.017","article-title":"The effect of nitrazepam on depression and curiosity in behavioral tests in mice: the role of potassium channels","volume":"791","author":"Nikoui","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2016.11.073_bib0280","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.pnpbp.2007.07.027","article-title":"Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus","volume":"32","author":"Garcia","year":"2008","journal-title":"Prog. Neuropsychopharmacol."},{"key":"10.1016\/j.biopha.2016.11.073_bib0285","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0022-3565(25)38715-X","article-title":"Adaptation of the N-methyl-D-aspartate receptor complex following chronic antidepressant treatments","volume":"269","author":"Paul","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.biopha.2016.11.073_bib0290","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/S0028-3908(02)00055-2","article-title":"Synergistic effect of uncompetitive NMDA receptor antagonists and antidepressant drugs in the forced swimming test in rats","volume":"42","author":"Rog\u00f3\u017c","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopha.2016.11.073_bib0295","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.euroneuro.2010.07.011","article-title":"Involvement of NMDA receptors and l-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effects of escitalopram in the forced swimming test","volume":"20","author":"Zomkowski","year":"2010","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.biopha.2016.11.073_bib0300","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.pbb.2007.07.018","article-title":"NMDA\/glutamate mechanism of antidepressant-like action of magnesium in forced swim test in mice","volume":"88","author":"Poleszak","year":"2007","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.biopha.2016.11.073_bib0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-3940(03)00306-9","article-title":"Melatonin exerts an antidepressant-like effect in the tail suspension test in mice: evidence for involvement of N-methyl-D-aspartate receptors and the L-arginine-nitric oxide pathway","volume":"343","author":"Mantovani","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.biopha.2016.11.073_bib0310","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1111\/j.1471-4159.2006.03988.x","article-title":"Nitric oxide, cell bioenergetics and neurodegeneration","volume":"97","author":"Moncada","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.biopha.2016.11.073_bib0315","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.biopha.2016.04.026","article-title":"Antidepressant effect of pramipexole in mice forced swimming test: a cross talk between dopamine receptor and NMDA\/nitric oxide\/cGMP pathway","volume":"81","author":"Ostadhadi","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2016.11.073_bib0320","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.pnpbp.2007.02.008","article-title":"Involvement of l-arginine\u2013nitric oxide\u2013cyclic guanosine monophosphate pathway in the antidepressant-like effect of venlafaxine in mice","volume":"31","author":"Dhir","year":"2007","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.biopha.2016.11.073_bib0325","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S0028-3908(03)00030-3","article-title":"Serotonergic mediation of the antidepressant-like effects of nitric oxide synthase inhibitors","volume":"44","author":"Harkin","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopha.2016.11.073_bib0330","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S2005-2901(10)60006-4","article-title":"Evaluation of the analgesic effect of dextromethorphan and its interaction with nitric oxide on sciatic nerve ligated rats","volume":"3","author":"Karimi","year":"2010","journal-title":"J. Acupunct. Meridian. Stud."},{"key":"10.1016\/j.biopha.2016.11.073_bib0335","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1152\/physrev.1995.75.4.725","article-title":"Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms","volume":"75","author":"Beavo","year":"1995","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.biopha.2016.11.073_bib0340","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.neuint.2004.03.015","article-title":"Specific localized expression of cGMP PDEs in Purkinje neurons and macrophages","volume":"45","author":"Bender","year":"2004","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.biopha.2016.11.073_bib0345","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1111\/j.0953-816X.2004.03327.x","article-title":"Species differences in the localization of cGMP\u2013producing and NO\u2013responsive elements in the mouse and rat hippocampus using cGMP immunocytochemistry","volume":"19","author":"Van Staveren","year":"2004","journal-title":"Eur. J. Neurosci."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332216312124?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332216312124?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T22:26:32Z","timestamp":1749767192000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332216312124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":69,"alternative-id":["S0753332216312124"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2016.11.073","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of NMDA receptor and nitric oxide\/cyclic guanosine monophosphate pathway in the antidepressant-like effect of dextromethorphan in mice forced swimming test and tail suspension test","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2016.11.073","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}